Lucía G. D.
- Country
- Spain
- Department
- Neurology
Research Overview
- Phase 3 Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
- Phase 3 Randomized Open-label Study on Efficacy and Safety of Vutrisiran vs. Patisiran in Hereditary Transthyretin Amyloidosis Patients
- Efficacy and Safety of Nipocalimab in Adults with Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 61 of 156 partner sites.
Specializations
Neuromuscular Disorders
This investigator specializes in treating patients with ocular myasthenia gravis, focusing on innovative therapeutic approaches for managing this challenging autoimmune condition affecting eye muscles.
- Autoimmune neuromuscular junction disorders
- Ocular muscle weakness management
- Novel antibody therapeutics
Hereditary Disorders
The investigator has extensive experience in treating hereditary transthyretin amyloidosis and its variants, particularly focusing on polyneuropathy manifestations of the condition.
- Hereditary amyloidosis treatment
- Transthyretin-mediated disorders
- Genetic polyneuropathies
Inflammatory Neuropathies
A significant focus of the investigator's work involves treating chronic inflammatory demyelinating polyneuropathy, exploring new therapeutic approaches for this chronic autoimmune condition.
- Autoimmune neuropathies
- Demyelinating disorders
- Immunotherapy applications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.